Monday, January 24, 2022
wellness India Expo
Home InDepth

InDepth

Critical analysis of various market situations that demand deep reviews is the primary feature of this section. It highlights the influential factors that guide demand or output, hinder or allow flow and finally the real inside picture.

Latest
Biotech

High adoption of biologics to drive Arthritis Therapeutics market gains

BioVoice News Desk -
260
BioPharma

Monoclonal antibodies to dominate global multiple sclerosis drugs market

BioVoice Correspondent -
246
Biosupplier

Productive partnerships in microfluidics likely to boost cell separation tech market

BioVoice News Desk -
155
InDepth

India’s biosimilars market stays buoyant

BioVoice News Desk -
376
Biotech

Integrating technologies to design better healthcare interventions

BioVoice News Desk -
280
Environment

Transplanting instead of felling can salvage Delhi’s green cover

BioVoice Correspondent -
211
Agriculture

Agricultural intensification not a “blueprint” for sustainable development?

BioVoice Correspondent -
230
BioComputing

Molecular simulation technology to effectively create new drug candidates

BioVoice Correspondent -
160
R&D

Commonly used drugs affect our gut bacteria

BioVoice Correspondent -
318
Environment

Mushroom based enzymes from Novozymes to help in fighting climatic change

BioVoice Correspondent -
590
123Page 1 of 3

Face to Face

Face to Face

“We are constantly strengthening our presence in India”

Rahul Koul -
263
David Schwaas, Director, Marketing & Distribution, Biopharma, Freudenberg Medical shares details about the company's business operations, product offerings, future plans and much more.

Chat with BioVoice

Chat with BioVoice

“We aim to grow scale across research, product lines & infrastructure”

Rahul Koul -
177
Gaurav Kaushik, Managing Director & CEO, Meteoric Biopharmaceuticals says that in 2022 his company's focus will be on expanding the production capability and yield of this particular strain of probiotics..................

“Medical imaging technology business is Fujifilm’s core growth driver in India”

“IQVIA offers a custom-built delivery model for biotech industry”

R&D

Events

© Copyright © 2018-2020 BioVoiceNews.com All rights reserved.